Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tangen Biosciences has developed the TangenDx platform, a portable isothermal nucleic acid amplification diagnostic system (GeneSpark instrument and disposable TangenDx disc) that can detect dozens of DNA/RNA targets from diverse specimen types with high sensitivity and specificity at the point-of-care; the company has advanced assays for sepsis/bloodstream infections, fungal and bacterial panels, antibiotic resistance, biothreat agents including anthrax, and respiratory viruses such as SARS-CoV-2, influenza A/B, and RSV into clinical and near-commercial use with BARDA, NIH and other grant support.[1][3][5][6][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tangen Biosciences.